「Antitumor effect of regorafenib on microRNA expression in hepatocellular carcinoma cell lines」の関連論文
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
Genome-scale CRISPR/Cas9 screening for gemcitabine modulators in pancreatic cancer
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Doublecortin-like kinase 1 expression is induced by alternative NF-κB signaling in human lung cancer cells
-
The mechanistic role of fatty acid binding protein 7 (FABP7) in tumor proliferation
-
Hernandezine induces multiple cancer cell death
-
Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma (本文)
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma (本文)
-
MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer (本文)
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
-
Escin inhibits angiogenesis by suppressing interleukin-8 and vascular endothelial growth factor production by blocking nuclear factor-κB activation in pancreatic cancer cell lines
-
Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model
-
Studies on the roles of EMT-associated microRNAs in cervical cancer and aggressive endometrial cancer
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
Epigenomic dysregulation in AFP-producing gastric cancer
-
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells
-
Osteogenic cocktail induces calcifications in human breast cancer cell line via placental alkaline phosphatase expression.
-
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer
-
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer
-
Effects of Senkyunolide I on ischemic cell injury and neurogenesis
-
Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma
-
Influence of human adipose stem cells on prostate cancer cell growth
-
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway
-
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Development of antisense oligonucleotides for suppressing breast cancer cell proliferation and the system for evaluating drug response of cardiomyocytes
-
Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice (本文)
-
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
-
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3 (本文)
-
Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice
-
Role of Tet2-deficient immune cells in lung cancer - a model of clonal hematopoiesis-derived immune cells in solid cancers
-
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
-
Targeting tumor-intrinsic Nuclear Factor-kappa B signaling pathway for the discovery of anti-metastatic drug candidates from natural recourses
-
Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer
-
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function
-
Glycan profile of signet ring cell gastric cancer and potential applicability of lectin drug conjugate therapy